Clinical trial
Ziprasidone for the Treatment of Generalized Anxiety Comorbidity in Patients With Bipolar Disorder
NCT00374543 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ziprasidone for the Treatment of Generalized Anxiety Comorbidity in Patients With Bipolar Disorder
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- February 28, 2006
- Completion date
- November 30, 2008
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.